Successful  	Successful  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	I-NP
bisphosphonate-related  	bisphosphonate-related  	 JJ	I-NP
osteonecrosis  	osteonecrosis  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
jaw  	jaw  	 NN	I-NP
( 	( 	 -LRB-	O
BRONJ 	BRONJ 	 NNP	B-NP
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
sitafloxacin 	sitafloxacin 	 NNS	B-NP
:  	:  	 :	O
new  	new  	 JJ	O
strategies  	strategies  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
BRONJ  	BRONJ  	 NNP	B-NP
BRONJ  	BRONJ  	 NNP	I-NP
has  	has  	 VBZ	O
become  	become  	 VBN	O
a  	a  	 DT	O
well-known 	well-known 	 JJ	O
,  	,  	 ,	O
occasionally  	occasionally  	 RB	O
severe  	severe  	 JJ	O
side  	side  	 NN	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
bisphosphonate  	bisphosphonate  	 JJ	I-NP
therapy 	therapy 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
a  	a  	 DT	O
clinical  	clinical  	 JJ	B-NP
problem 	problem 	 NN	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
treatment  	treatment  	 NN	B-NP
recommendations  	recommendations  	 NNS	I-NP
exist 	exist 	 VBP	O
,  	,  	 ,	O
no  	no  	 DT	O
standard  	standard  	 JJ	O
therapy  	therapy  	 NN	O
has  	has  	 VBZ	O
yet  	yet  	 RB	O
been  	been  	 VBN	O
established  	established  	 VBN	O
for  	for  	 IN	O
BRONJ 	BRONJ 	 NNP	B-NP
.  	.  	 .	O
Also 	Also 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
recommendations  	recommendations  	 NNS	B-NP
identify  	identify  	 VBP	O
several  	several  	 JJ	O
limitations  	limitations  	 NNS	O
that  	that  	 WDT	O
prevent  	prevent  	 VBP	O
clinicians  	clinicians  	 VBN	O
from  	from  	 IN	O
confidently  	confidently  	 FW	O
diagnosing  	diagnosing  	 FW	B-NP
BRONJ 	BRONJ 	 FW	I-NP
.  	.  	 .	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
establish  	establish  	 VB	O
a  	a  	 DT	O
treatment  	treatment  	 NN	B-NP
approach  	approach  	 NN	I-NP
in  	in  	 IN	O
which  	which  	 WDT	O
all  	all  	 DT	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
exposed 	exposed 	 VBN	O
,  	,  	 ,	O
infected  	infected  	 JJ	O
bone  	bone  	 NN	O
or  	or  	 CC	O
intraoral 	intraoral 	 CD	B-NP
/ 	/ 	 CD	I-NP
extraoral  	extraoral  	 CD	I-NP
fistulas  	fistulas  	 NNS	I-NP
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
sitafloxacin  	sitafloxacin  	 NNS	B-NP
( 	( 	 -LRB-	O
STFX 	STFX 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
examined  	examined  	 VBD	O
20  	20  	 CD	O
BRONJ  	BRONJ  	 NN	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
fourteen  	fourteen  	 VBG	O
with  	with  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
six  	six  	 CD	O
with  	with  	 IN	O
osteoporosis 	osteoporosis 	 NN	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
used  	used  	 VBD	O
the  	the  	 DT	O
current  	current  	 JJ	O
updated  	updated  	 JJ	O
definition  	definition  	 NN	O
of  	of  	 IN	O
BRONJ  	BRONJ  	 NNP	B-NP
( 	( 	 -LRB-	O
12 	12 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
except  	except  	 IN	O
that  	that  	 WDT	O
we  	we  	 PRP	O
included  	included  	 VBD	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
had  	had  	 VBD	O
shown  	shown  	 VBN	O
symptoms  	symptoms  	 NNS	B-NP
for  	for  	 IN	O
a  	a  	 DT	O
minimum  	minimum  	 NN	O
of  	of  	 IN	O
only  	only  	 RB	O
one  	one  	 CD	O
month 	month 	 NN	O
,  	,  	 ,	O
rather  	rather  	 RB	O
than  	than  	 IN	O
two  	two  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
half  	half  	 NN	O
of  	of  	 IN	O
our  	our  	 PRP$	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
infection  	infection  	 NN	B-NP
with  	with  	 IN	O
no  	no  	 DT	O
exposed 	exposed 	 NN	O
,  	,  	 ,	O
necrotic  	necrotic  	 JJ	B-NP
bone  	bone  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
oral  	oral  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
purposely  	purposely  	 RB	O
excluded  	excluded  	 VBN	O
all  	all  	 DT	O
patients  	patients  	 NNS	O
exhibiting  	exhibiting  	 VBG	O
no  	no  	 DT	O
signs  	signs  	 NNS	O
of  	of  	 IN	O
infection  	infection  	 NN	B-NP
( 	( 	 -LRB-	O
current  	current  	 JJ	O
Stages  	Stages  	 NNP	O
0  	0  	 CD	O
and  	and  	 CC	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
each  	each  	 DT	O
potentially  	potentially  	 RB	O
causative  	causative  	 JJ	B-NP
organism  	organism  	 NN	I-NP
was  	was  	 VBD	O
isolated  	isolated  	 VBN	O
from  	from  	 IN	O
pus  	pus  	 VBG	O
collected  	collected  	 VBN	O
from  	from  	 IN	O
an  	an  	 DT	O
intraoral  	intraoral  	 NN	B-NP
or  	or  	 CC	O
extraoral  	extraoral  	 JJ	B-NP
fistula  	fistula  	 NN	I-NP
in  	in  	 IN	O
ten  	ten  	 JJ	O
patients  	patients  	 NNS	O
on  	on  	 IN	O
their  	their  	 PRP$	O
first  	first  	 JJ	O
visit  	visit  	 NN	O
to  	to  	 TO	O
our  	our  	 PRP$	O
department.  	department.  	 CD	O
90 	90 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
received  	received  	 VBN	O
a  	a  	 DT	O
course  	course  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
common  	common  	 JJ	O
antibiotics 	antibiotics 	 NN	O
.  	.  	 .	O
STFX  	STFX  	 NNP	B-NP
was  	was  	 VBD	O
administered  	administered  	 VBN	O
to  	to  	 TO	O
all  	all  	 DT	O
patients 	patients 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
then  	then  	 RB	O
re-evaluated  	re-evaluated  	 JJ	O
the  	the  	 DT	O
lesion  	lesion  	 NN	B-NP
every  	every  	 DT	O
other  	other  	 JJ	O
week 	week 	 NN	B-NP
,  	,  	 ,	O
to  	to  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
epithelialization  	epithelialization  	 NN	B-NP
was  	was  	 VBD	O
present 	present 	 JJ	O
.  	.  	 .	O
We  	We  	 PRP	O
recommended  	recommended  	 VBD	O
surgical  	surgical  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	O
cases  	cases  	 NNS	O
without  	without  	 IN	O
epithelialization  	epithelialization  	 NN	B-NP
within  	within  	 IN	O
4  	4  	 CD	O
weeks  	weeks  	 NNS	O
after  	after  	 IN	O
the  	the  	 DT	O
onset  	onset  	 NN	O
of  	of  	 IN	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	I-NP
STFX  	STFX  	 NNP	I-NP
even  	even  	 RB	O
if  	if  	 IN	O
bone  	bone  	 NN	O
was  	was  	 VBD	O
not  	not  	 RB	O
exposed  	exposed  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
lesion.  	lesion.  	 CD	B-NP
19  	19  	 CD	O
of  	of  	 IN	O
our  	our  	 PRP$	O
20  	20  	 CD	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
Stages  	Stages  	 NNP	O
2-3  	2-3  	 NNP	O
BRONJ  	BRONJ  	 NNP	O
responded  	responded  	 VBD	O
to  	to  	 TO	O
2-10  	2-10  	 CD	O
weeks  	weeks  	 NNS	O
of  	of  	 IN	O
STFX  	STFX  	 NNP	B-NP
treatment  	treatment  	 NN	I-NP
by  	by  	 IN	O
entering  	entering  	 VBG	O
either  	either  	 RB	O
a  	a  	 DT	O
remission  	remission  	 NN	O
or  	or  	 CC	O
healed  	healed  	 JJ	O
phase 	phase 	 NN	O
.  	.  	 .	O
While  	While  	 IN	O
surgery  	surgery  	 NN	O
was  	was  	 VBD	O
done  	done  	 VBN	O
on  	on  	 IN	O
thirteen  	thirteen  	 JJ	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
seven  	seven  	 CD	O
others  	others  	 NNS	O
reached  	reached  	 VBD	O
such  	such  	 JJ	O
phases  	phases  	 NNS	O
without  	without  	 IN	O
surgery 	surgery 	 NN	O
.  	.  	 .	O
Every  	Every  	 DT	O
patient  	patient  	 NN	O
had  	had  	 VBD	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
bacterial  	bacterial  	 JJ	B-NP
species  	species  	 NNS	I-NP
that  	that  	 WDT	O
showed  	showed  	 VBD	B-NP
resistance  	resistance  	 NN	I-NP
to  	to  	 TO	O
common  	common  	 JJ	O
antibiotics 	antibiotics 	 NN	O
.  	.  	 .	O
All  	All  	 DT	O
species  	species  	 NN	B-NP
in  	in  	 IN	O
all  	all  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
susceptible  	susceptible  	 JJ	O
to  	to  	 TO	O
STFX 	STFX 	 NNP	B-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
STFX 	STFX 	 NNP	B-NP
,  	,  	 ,	O
with  	with  	 IN	O
or  	or  	 CC	O
without  	without  	 IN	O
minor  	minor  	 JJ	O
surgery 	surgery 	 NN	O
,  	,  	 ,	O
gives  	gives  	 VBZ	O
a  	a  	 DT	O
high  	high  	 JJ	O
probability  	probability  	 NN	B-NP
of  	of  	 IN	I-NP
controlling  	controlling  	 VBG	I-NP
infection  	infection  	 NN	I-NP
in  	in  	 IN	O
BRONJ  	BRONJ  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
persistent  	persistent  	 JJ	O
infection  	infection  	 NN	B-NP
after  	after  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
common  	common  	 JJ	O
antibiotics 	antibiotics 	 NN	O
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
remission  	remission  	 VB	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
complete  	complete  	 JJ	O
healing  	healing  	 NN	O
in  	in  	 IN	O
95 	95 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
